Director of Rare Disease Market Access Strategy
Biogen
Director of Rare Disease Market Access Strategy
Biogen
Develops therapies for neurological disorders
As the Director of Rare Disease Market Access Strategy, you will spearhead the development and execution of the Market Access & Reimbursement (MA&R) strategy for rare diseases such as SMA and ALS. This pivotal role requires you to construct payer messaging, devise pricing and contracting strategies, and ensure seamless coordination across all MA&R functions. Reporting to the Head of Rare Disease Access Strategy within the US Market Access & Reimbursement division, you will guide a specialized team in optimizing access for SMA and ALS. Your efforts will align closely with the Rare Disease Franchise, offering invaluable contributions to our overarching business goals. Through varied sentence structures, you will convey complex strategies with clarity, ensuring integration into the broader organizational framework.
What You’ll Do:
• Develop and execute comprehensive market access strategies to support the SMA and ALS brands across commercial and government payer segments.
• Lead cross-functional planning and execution across all MA&R functions to ensure alignment with approved strategies.
• Ensure coordination and alignment with the Rare Disease Franchise for overall strategy and messaging.
• Deliver impactful value propositions, messaging, and promotional materials tailored to key customer segments.
• Champion pull-through activities to ensure access optimization.
• Partner with Medical, HEOR, Global V&A to support evidence generation for access strategy.
• Define and drive the contracting strategy in collaboration with Brand, legal, and finance.
• Develop pricing and innovative contracting strategies, such as value-based contracts.
• Work with cross-functional teams to model scenario-based business cases for senior leadership.
• Research, compile, analyze, and assess market landscape data/trends for customized solutions.
• Support development of free drug and co-pay support strategies.
• Support development of SP and SD strategies to optimize patient access.
• Execute and support training of MA&R RADs and NADs in alignment with approved strategies and materials.
• Lead initiatives to evaluate MA&R performance in support of the Rare Disease Franchise.
• Lead and support multiple cross-functional teams as a market access expert in various projects.
• Support pipeline activities for Biogen’s pipeline assets for SMA and ALS populations.
Who You Are:
You are a proactive team leader with strong communication and analytic abilities, deeply knowledgeable about the US healthcare system. You bring a collaborative spirit, ready to navigate complex market dynamics and influence cross-functional teams with clarity and precision. Your strategic mindset allows you to translate data into actionable strategies, fostering growth within our organization. Your dedication to high-quality, accurate work under time constraints makes you an invaluable asset to our team.
Required Skills:
• Bachelor’s degree required, MBA preferred.
• 10+ years of experience in U.S. market access, payer marketing, pricing, or related fields within the pharmaceutical or biotech industry.
• Ability to work cross-functionally to develop payer messaging, contracting strategy, build business cases, and develop training/communication plans for field teams.
• Knowledge of standard payer research methodologies, financial analyses, and gross-to-net dynamics.
• Excellent analytical, strategic thinking, and critical thinking skills with the ability to translate data into strategy.
• Ability to develop and deliver clear, compelling presentations on complex pricing topics to senior-level executive audience.
#LI-NP1
Job Level: Management
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about Biogen.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.
Explore more opportunities at Biogen